MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Compatible

Ipinnia XL 4mg tablets (Ethypharm UK Ltd)

Explore other Ropinirole formulations Explore other Ropinirole 4mg modified-release tablets suppliers

Stability Notes

No special requirements for storage.

Provenance

This compatibility recommendation is derived from Raponer XL tablets (Accord Healthcare Ltd).

No Stability Information

Ipinnia XL 6mg tablets (Ethypharm UK Ltd)

Explore other Ropinirole formulations Explore other Ropinirole 6mg modified-release tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

Compatible

Ipinnia XL 8mg tablets (Ethypharm UK Ltd)

Explore other Ropinirole formulations Explore other Ropinirole 8mg modified-release tablets suppliers

Stability Notes

No special requirements for storage.

Provenance

This compatibility recommendation is derived from Raponer XL tablets (Accord Healthcare Ltd).

No Stability Information

Iqirvo 80mg tablets (Ipsen Ltd)

Explore other Elafibranor formulations Explore other Elafibranor 80mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

Use with caution

Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets (A A H Pharmaceuticals Ltd)

Explore other Irbesartan + Hydrochlorothiazide formulations Explore other Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets suppliers

Stability Notes

Store in airtight containers. Protect from light, moisture and freezing.

Provenance

This compatibility recommendation is derived from CoAprovel 150mg/12.5mg tablets (Sanofi).

Use with caution

Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets (Accord-UK Ltd)

Explore other Irbesartan + Hydrochlorothiazide formulations Explore other Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets suppliers

Stability Notes

Store in airtight containers. Protect from light, moisture and freezing.

Provenance

This compatibility recommendation is derived from CoAprovel 150mg/12.5mg tablets (Sanofi).

Use with caution

Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets (Alliance Healthcare (Distribution) Ltd)

Explore other Irbesartan + Hydrochlorothiazide formulations Explore other Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets suppliers

Stability Notes

Store in airtight containers. Protect from light, moisture and freezing.

Provenance

This compatibility recommendation is derived from CoAprovel 150mg/12.5mg tablets (Sanofi).

Use with caution

Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets (Bristol Laboratories Ltd)

Explore other Irbesartan + Hydrochlorothiazide formulations Explore other Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets suppliers

Stability Notes

Store in airtight containers. Protect from light, moisture and freezing.

Provenance

This compatibility recommendation is derived from CoAprovel 150mg/12.5mg tablets (Sanofi).

Use with caution

Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets (Brown & Burk UK Ltd)

Explore other Irbesartan + Hydrochlorothiazide formulations Explore other Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets suppliers

Stability Notes

Store in airtight containers. Protect from light, moisture and freezing.

Provenance

This compatibility recommendation is derived from CoAprovel 150mg/12.5mg tablets (Sanofi).

Use with caution

Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets (Macleods Pharma UK Ltd)

Explore other Irbesartan + Hydrochlorothiazide formulations Explore other Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets suppliers

Stability Notes

Store in airtight containers. Protect from light, moisture and freezing.

Provenance

This compatibility recommendation is derived from CoAprovel 150mg/12.5mg tablets (Sanofi).

Use with caution

Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets (Medihealth (Northern) Ltd)

Explore other Irbesartan + Hydrochlorothiazide formulations Explore other Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets suppliers

Stability Notes

Store in airtight containers. Protect from light, moisture and freezing.

Provenance

This compatibility recommendation is derived from CoAprovel 150mg/12.5mg tablets (Sanofi).

Use with caution

Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets (Milpharm Ltd)

Explore other Irbesartan + Hydrochlorothiazide formulations Explore other Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets suppliers

Stability Notes

Store in airtight containers. Protect from light, moisture and freezing.

Provenance

This compatibility recommendation is derived from CoAprovel 150mg/12.5mg tablets (Sanofi).

Use with caution

Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets (Sigma Pharmaceuticals Plc)

Explore other Irbesartan + Hydrochlorothiazide formulations Explore other Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets suppliers

Stability Notes

Store in airtight containers. Protect from light, moisture and freezing.

Provenance

This compatibility recommendation is derived from CoAprovel 150mg/12.5mg tablets (Sanofi).

Compatible

Irbesartan 150mg tablets (A A H Pharmaceuticals Ltd)

Explore other Irbesartan formulations Explore other Irbesartan 150mg tablets suppliers

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Aprovel 150mg tablets (Sanofi).

Compatible

Irbesartan 150mg tablets (Alliance Healthcare (Distribution) Ltd)

Explore other Irbesartan formulations Explore other Irbesartan 150mg tablets suppliers

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Aprovel 150mg tablets (Sanofi).

Print this list

Compatible

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.

Use with caution

Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.

Incompatible

Medicines under this category are not suitable for use inside MCAs.

No Stability Information

We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.